From June 5th to June 7th, Cergentis will be attending the Cell Line Development & Engineering Conference in San Diego, CA.

Brian Mickus, of Gilead Sciences, will give a presentation, entitled "TLA Targeted Sequencing for De-Risking and Accelerating Clone Selection", on June 6, at 2:45 PM at the Cell Line Development & Engineering stream of the conference.

If you wish to learn more about the application of the TLA technology in the assessment of genetic stability or clonality of transgenic cell lines, or if you wish to meet us at the conference, please contact us.